PMV Pharmaceuticals, Inc. - PMVP
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 05, 2026 | — | A | A | 42,000.0 | 0.0 | 0.0 | 42,000.0 | View | |
| Jun 05, 2026 | — | A | A | 42,000.0 | 0.0 | 0.0 | 42,000.0 | View | |
| Jun 05, 2026 | — | G | A | 42,000.0 | 0.0 | 0.0 | 42,000.0 | View | |
| Jun 05, 2026 | — | G | D | 42,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 05, 2026 | — | A | A | 42,000.0 | 0.0 | 0.0 | 42,000.0 | View | |
| Jun 05, 2026 | — | A | A | 42,000.0 | 0.0 | 0.0 | 42,000.0 | View | |
| Jun 05, 2026 | — | A | A | 42,000.0 | 0.0 | 0.0 | 42,000.0 | View | |
| Mar 09, 2026 | President and CEO | A | A | 744,960.0 | 0.0 | 0.0 | 744,960.0 | View | |
| Mar 09, 2026 | Chief Development Officer | A | A | 303,310.0 | 0.0 | 0.0 | 303,310.0 | View | |
| Mar 09, 2026 | General Counsel & COO | A | A | 319,270.0 | 0.0 | 0.0 | 319,270.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | A | A | 240,000.0 | 0.0 | 0.0 | 240,000.0 | View |